ArthroCare To Pay $74M To End Stock Inflation Action
ArthroCare Corp. on Monday announced a $74 million settlement with a class of investors who alleged the medical device maker inflated its stock by selling a spinal surgery device to doctors...To view the full article, register now.
Already a subscriber? Click here to view full article